Drug, Radiation : After a single intravenous injection of 370MBq of [F-18]Florastamin, PET/CT images are acquired.

2 trials

Sponsors

Korea Cancer Center Hospital, FutureChem

Phase 1

Evaluation of new PET tracer, [F-18]Florastamin for diagnosing prostate cancer: Phase I clinical trial

RecruitingKCT0004817

Start: 2020-01-08Target: 10Updated: 2020-03-23

Unknown Phase

Evaluation of new PET tracer, [F-18]Florastamin for diagnosing prostate cancer

RecruitingKCT0003924

Korea Cancer Center Hospital

Start: 2019-02-11Target: 6Updated: 2019-05-20

Related Papers

A microdose clinical trial to evaluate [<sup>18</sup>F]Florastamin as a positron emission tomography imaging agent in patients with prostate cancer.

2020-05-2614 citations